4//SEC Filing
Thompson Elizabeth H.Z. 4
Accession 0001415889-25-009068
CIK 0001070494other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 7:52 PM ET
Size
7.9 KB
Accession
0001415889-25-009068
Insider Transaction Report
Form 4
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
Transactions
- Award
Stock Option (Right to Buy)
2025-03-24+91,395→ 91,395 totalExercise: $17.23Exp: 2035-03-23→ Common Stock (91,395 underlying) - Award
Restricted Stock Units
2025-03-24+26,861→ 26,861 total→ Common Stock (26,861 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning March 24, 2026.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001861477
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 7:52 PM ET
- Size
- 7.9 KB